Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg because ...
A multi-center study of a pill that combines two drugs for hypertension shows significant benefit for people with hard-to-control high blood pressure. The study, conducted at the University of ...
A drug company on Friday announced the recall of eight more lots of irbesartan blood pressure medication after testing revealed the drugs contained trace amounts of a carcinogen. Prinston ...
Another voluntary recall of medications used in the treatment of high blood pressure has been issued due to the detection in the active pharmaceutical ingredient of an impurity considered probably ...
LONG BEACH, Calif. -- Sparsentan (Filspari) led to more complete and partial remissions of focal segmental glomerulosclerosis (FSGS) compared with irbesartan (Avapro), the phase III DUPLEX trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback